Showing results (1-10 of 240) with videos related to
Sort By:
Pageof 24
Journal of Neuropathology and Experimental Neurology|May 26, 1998
Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivityM C Irizarry, W Growdon, T Gomez-Isla, et al.Archives of Neurology|July 25, 1998
Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer diseaseM J McNamara, T Gomez-Isla, B T HymanJournal of Neuropathology and Experimental Neurology|December 23, 1998
Abeta associated neuropil changes: correlation with neuronal loss and dementiaR B Knowles, T Gomez-Isla, B T HymanThe Journal of Neuropsychiatry and Clinical Neurosciences|August 10, 1999
Risperidone treatment of behavioral disturbances in outpatients with dementiaM C Irizarry, S N Ghaemi, E R Lee-Cherry, et al.Journal of Neuropathology and Experimental Neurology|October 9, 2001
Alzheimer disease therapeuticsM C Irizarry, B T HymanThe American Journal of Pathology|January 6, 2001
beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with agingM C Irizarry, J J Locascio, B T HymanNeurology|August 1, 1996
Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's diseaseJ H Growdon, J J Locascio, S Corkin, et al.Archives of Neurology|October 28, 1997
Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer diseaseA E Clatworthy, T Gomez-Isla, G W Rebeck, et al.Annals of Neurology|August 1, 1995
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathyS M Greenberg, G W Rebeck, J P Vonsattel, et al.Annals of Neurology|July 1, 1996
Apolipoprotein E and cognitive change in an elderly populationB T Hyman, T Gomez-Isla, M Briggs, et al.Pageof 24